๐Ÿ•ต๏ธ RANI Therapeutics Holdings, Inc. ($RANI)

SEC insider & ownership activity, last 12 months ยท CIK 1856725 ยท every row links its SEC filing

Over the last 12 months insiders sold $15.7M against $1.3M of open-market buying. South CONE Investments Limited Partnership sold $15.7M in discretionary trades (Oct). One red-flag 8-K in the window: Delisting notice (3.01), May 11, 2026.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net -$14.5M Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net -$301 Mar 2026: net -$301 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$50K
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

2 buyers, $1.3M (4 lots) ยท 3 sellers, $15.7M (4 lots)

InsiderBuysBoughtSellsSoldLast
South CONE Investments Limited Partnership0โ€“ 2$15.7MOct 21, 2025
Mir A. Imran3$1.3M 0โ€“Jul 21, 2026
Imran Talat1$25K 1$11KJul 17, 2026
Javadi Alireza0โ€“ 1$301Mar 27, 2026

5%+ holders

HolderStakeClassScheduleEvent
Mir A Imran 22.1% 13DOct 23, 2025 filing โ†—
Incube LABS, L.L.C. 18.7% 13DOct 23, 2025 filing โ†—
Raymond Debbane 10.0% 13GOct 23, 2025 filing โ†—
Srinivas Akkaraju 9.9% 13DMay 26, 2026 filing โ†—
AWM Investment Company, Inc. 9.9% 13GFeb 13, 2026 filing โ†—
RA Capital Management, L.P. 9.9% 13GOct 30, 2025 filing โ†—
Peter Kolchinsky 9.9% 13GOct 30, 2025 filing โ†—
Rajeev Shah 9.9% 13GOct 30, 2025 filing โ†—
RA Capital Healthcare Fund, L.P. 9.9% 13GOct 30, 2025 filing โ†—
Invus Public Equities, L.P. 8.8% 13GOct 23, 2025 filing โ†—
Invus Public Equities Advisors, LLC 8.8% 13GOct 23, 2025 filing โ†—
Invus Global Management, LLC 8.8% 13GOct 23, 2025 filing โ†—
Siren, L.L.C. 8.8% 13GOct 23, 2025 filing โ†—
Vanguard Capital Management 5.1% 13GApr 30, 2026 filing โ†—
Samsara Biocapital, L.P. 5.0% 13DMay 26, 2026 filing โ†—
Samsara Biocapital GP, LLC 5.0% 13DMay 26, 2026 filing โ†—
Samsara Opportunity Fund, L.P. 5.0% 13DMay 26, 2026 filing โ†—
Samsara Opportunity Fund GP, LLC 5.0% 13DMay 26, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)Jun 24, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 24, 2026 filing โ†—
Shareholder vote (5.07)May 28, 2026 filing โ†—
Other events (8.01)May 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 26, 2026 filing โ†—
Earnings (2.02)May 11, 2026 filing โ†—
Delisting notice (3.01)May 11, 2026 filing โ†—
Officer/director changes (5.02)May 11, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 11, 2026 filing โ†—
Earnings (2.02)Mar 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 26, 2026 filing โ†—
Agreement terminated (1.02)Dec 31, 2025 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Dec 31, 2025 filing โ†—
Charter/bylaw changes (5.03)Dec 31, 2025 filing โ†—
Shareholder vote (5.07)Dec 31, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 31, 2025 filing โ†—
Earnings (2.02)Nov 6, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 6, 2025 filing โ†—
Officer/director changes (5.02)Oct 22, 2025 filing โ†—
Other events (8.01)Oct 22, 2025 filing โ†—
Material agreement (1.01)Oct 16, 2025 filing โ†—
New financial obligation (2.03)Oct 16, 2025 filing โ†—
Unregistered equity sale (3.02)Oct 16, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 16, 2025 filing โ†—
Earnings (2.02)Aug 7, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing โ†—